127 related articles for article (PubMed ID: 10436844)
21. Molecular therapy in pancreatic adenocarcinoma.
MacKenzie MJ
Lancet Oncol; 2004 Sep; 5(9):541-9. PubMed ID: 15337483
[TBL] [Abstract][Full Text] [Related]
22. New treatment possibilities for pancreatic and biliary tumours.
Van Cutsem E; Haustermans K; Van Steenbergen W
Ann Oncol; 2000; 11 Suppl 3():165-9. PubMed ID: 11079135
[No Abstract] [Full Text] [Related]
23. [Liver, pancreas, biliary tract cancer].
Miyazaki M
Gan To Kagaku Ryoho; 2012 Oct; 39(10):1477. PubMed ID: 23130370
[No Abstract] [Full Text] [Related]
24. [Liver, pancreas, biliary tract cancer].
Miyazaki M
Gan To Kagaku Ryoho; 2013 Oct; 40(10):1295-6. PubMed ID: 24312978
[No Abstract] [Full Text] [Related]
25. Biologic therapies for advanced pancreatic cancer.
He AR; Lindenberg AP; Marshall JL
Expert Rev Anticancer Ther; 2008 Aug; 8(8):1331-8. PubMed ID: 18699769
[TBL] [Abstract][Full Text] [Related]
26. [Liver, pancreas, biliary tract cancer-2011 update].
Arii S
Gan To Kagaku Ryoho; 2011 Oct; 38(10):1599. PubMed ID: 22081855
[No Abstract] [Full Text] [Related]
27. Preoperative chemoradiation followed by surgical resection for resectable pancreatic cancer: a review of current results.
Chua TC; Saxena A
Surg Oncol; 2011 Dec; 20(4):e161-8. PubMed ID: 21704510
[TBL] [Abstract][Full Text] [Related]
28. Lentivirus-mediated shRNA interference targeting vascular endothelial growth factor inhibits angiogenesis and progression of human pancreatic carcinoma.
Zhao X; Zhu DM; Gan WJ; Li Z; Zhang JL; Zhao H; Zhou J; Li DC
Oncol Rep; 2013 Mar; 29(3):1019-26. PubMed ID: 23254994
[TBL] [Abstract][Full Text] [Related]
29. Multicentre phase I-II trial of capecitabine and oxaliplatin in combination with radiotherapy for unresectable pancreatic and biliary tract cancer: The CORGI-U study.
Gunnlaugsson A; Anderson H; Lind P; Glimelius B; Johnsson A
Radiother Oncol; 2010 Jun; 95(3):292-7. PubMed ID: 20451275
[TBL] [Abstract][Full Text] [Related]
30. K-ras mutation, p53 overexpression, and microsatellite instability in biliary tract cancers: a population-based study in China.
Rashid A; Ueki T; Gao YT; Houlihan PS; Wallace C; Wang BS; Shen MC; Deng J; Hsing AW
Clin Cancer Res; 2002 Oct; 8(10):3156-63. PubMed ID: 12374683
[TBL] [Abstract][Full Text] [Related]
31. [Prospective randomized trial comparing 1/2 FAM (5-fluorouracil (5-FU) + adriamycin + mitomycin C) versus palliative therapy for the treatment of unresectable pancreatic and biliary tract carcinomas (the 2nd trial in non-resectable patients). Japanese Study Group of Surgical Adjuvant Therapy for Carcinomas of the Pancreas and Biliary Tract].
Takada T; Kato H; Matsushiro T; Nimura Y; Nagakawa T; Nakayama T; Yamauchi H; Ogata Y; Shimada H; Miyakawa S; Yamaguchi A; Sakoda K; Yasuda H; Tsukada K; Yoshida K; Ashida H; Ishikawa Y; Kotoura Y; Kinoshita H; Kajiwara T; Watanabe G; Uchimura M; Funabiki T; Ikeda S; Okada S
Gan To Kagaku Ryoho; 1996 May; 23(6):707-14. PubMed ID: 8645022
[TBL] [Abstract][Full Text] [Related]
32. [Liver, Pancreas, Biliary Tract Cancer The Current Status and Future Perspective of Therapies for Advanced Biliary-Pancreatic Cancer].
Miyazaki M
Gan To Kagaku Ryoho; 2022 Oct; 49(10):1051-1053. PubMed ID: 36281594
[No Abstract] [Full Text] [Related]
33. Targeted therapies for killing tumor cells.
Gazdar AF; Minna JD
Proc Natl Acad Sci U S A; 2001 Aug; 98(18):10028-30. PubMed ID: 11526225
[No Abstract] [Full Text] [Related]
34. Cancers of the large bowel and hepatobiliary tract.
Treat J; Woolley PV
Cancer Chemother Biol Response Modif; 1992; 13():477-92. PubMed ID: 1327046
[No Abstract] [Full Text] [Related]
35. Clinical and genetic analysis of noncancerous and cancerous biliary epithelium in patients with pancreaticobiliary maljunction.
Nagai M; Watanabe M; Iwase T; Yamao K; Isaji S
World J Surg; 2002 Jan; 26(1):91-8. PubMed ID: 11898040
[TBL] [Abstract][Full Text] [Related]
36. Antitumor activity of an oncolytic adenovirus-delivered oncogene small interfering RNA.
Zhang YA; Nemunaitis J; Samuel SK; Chen P; Shen Y; Tong AW
Cancer Res; 2006 Oct; 66(19):9736-43. PubMed ID: 17018633
[TBL] [Abstract][Full Text] [Related]
37. Highlights of topic "Recent advances in hepato-biliary-pancreatic science".
Fujimoto J
J Hepatobiliary Pancreat Sci; 2015 Jul; 22(7):511. PubMed ID: 26100098
[No Abstract] [Full Text] [Related]
38. Biliopancreatic malignancy: screening the at risk patient with molecular markers.
Caldas C
Ann Oncol; 1999; 10 Suppl 4():153-6. PubMed ID: 10436811
[TBL] [Abstract][Full Text] [Related]
39. [The role of hemosorption in the combination therapy of biliary, pancreatic and duodenal tumors].
Ender LA; Agureev AI; Lobakov AI; Lechtman AM
Vopr Onkol; 1982; 28(9):104-8. PubMed ID: 6750913
[No Abstract] [Full Text] [Related]
40. [Intra-arterial infusion chemotherapy of cancer of the liver, biliary tract and pancreas with or without hyperthermia].
Miura T
Nihon Geka Gakkai Zasshi; 1984 Sep; 85(9):1147-50. PubMed ID: 6503977
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
